Open-Label Study Evaluating Synera® in the Treatment of Patients With Carpal Tunnel Syndrome

NCT00991068 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Carpal Tunnel Syndrome

Interventions

DRUG: Synera (lidocaine 70 mg and tetracaine 70 mg) topical patch

Sponsor

ZARS Pharma Inc.